Standard Cancer Prevention Package

US$869
NT$27,900 · you pay the hospital in NT$

Women: US$981 (NT$31,500). The price above is for men.

Book this checkup

Prefer to book it yourself? Call National Taiwan University Cancer Center on 02-2322-0322 ext. 231300, 231310 or use its website ↗. It's free; most hospitals take bookings in Chinese.

We book it with the hospital for you, from US$149, paid only after the hospital confirms. We reply by email with available dates, the confirmed price, and whether an English report is available.

Paying from a US account? HSA and FSA notes.

Share on LINE / 分享到 LINE

As published by the hospital · checked 2026-09-20

A premium-tier program with Low-dose chest CT, Abdominal ultrasound, Breast ultrasound, Pelvic (gynecologic) ultrasound and Thyroid ultrasound and a 61-test panel.

English report
Ask the hospital (we ask for you in Book it for me)

What stands out

Low-dose chest CT

Early lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.

Abdominal ultrasound

Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.

Breast ultrasound

Breast lumps; complements mammography, especially in dense breasts.

Pelvic (gynecologic) ultrasound

Uterus and ovary abnormalities (fibroids, cysts).

Every test, in English

61 tests listed, 42 of them on our shared test list, so they line up against other hospitals' packages.

Vitals1
Blood Count3
Liver Function4
Kidney & Electrolytes6
Lipids & Cardiometabolic5
Glucose2
Thyroid & Endocrine2
Tumor Markers4
Infection Serology1
Urine & Stool1
Cardiac1
Ultrasound4
CT Imaging1
Women's Health1
Men's Health1
Bone & Body Composition1
Eye3
ENT & Dental1
Show all 61 tests and what each screens for
TestScreens for
Vitals
Body composition analysisBody fat, muscle mass and water percentage.
Blood Count
Antinuclear antibody (ANA)Autoimmune disease screening (e.g. lupus).
Complete blood countAnemia, infection and blood cell disorders.
White blood cell differentialBreakdown of white cell types; infection, allergy and some blood cancers.
Liver Function
Alkaline phosphataseLiver, bile duct and bone conditions.
ALT (SGPT)Liver cell damage; the most common liver screening test.
AST (SGOT)Liver cell damage.
Gamma-GTBile duct and alcohol-related liver stress.
Kidney & Electrolytes
Blood urea nitrogenKidney function.
CalciumBone, parathyroid and kidney conditions.
CreatinineKidney function.
Estimated GFRKidney filtering capacity; stages chronic kidney disease.
Electrolytes (Na, K, Cl)Salt and fluid balance; kidney and hormone problems.
Uric acidGout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterolProtective cholesterol level.
High-sensitivity CRPInflammation linked to heart disease risk.
LDL cholesterolThe main cholesterol driving heart disease risk.
Total cholesterolCardiovascular risk.
TriglyceridesCardiovascular and pancreatitis risk.
Glucose
Fasting glucoseDiabetes and prediabetes.
Hemoglobin A1cAverage blood sugar over the past three months; diabetes.
Thyroid & Endocrine
Free T4Thyroid hormone level.
TSHThyroid function; the primary thyroid screening test.
Tumor Markers
AFPLiver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CEAColorectal and other GI cancer marker.
Free PSA ratioRefines prostate cancer risk when PSA is borderline.
PSAProstate cancer marker.
Infection Serology
Hepatitis B core antibodyPast or hidden hepatitis B exposure.
Urine & Stool
UrinalysisKidney disease, urinary infection, diabetes.
Cardiac
Resting ECGHeart rhythm and signs of prior heart damage.
Ultrasound
Abdominal ultrasoundLiver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Breast ultrasoundBreast lumps; complements mammography, especially in dense breasts.
Pelvic (gynecologic) ultrasoundUterus and ovary abnormalities (fibroids, cysts).
Thyroid ultrasoundThyroid nodules.
CT Imaging
Low-dose chest CTEarly lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.
Women's Health
MammographyBreast cancer; the standard screen for women 40+.
Men's Health
UroflowmetryProstate enlargement effect on urination.
Bone & Body Composition
Bone density (DXA)Osteoporosis and fracture risk.
Eye
Retinal (fundus) photographyDiabetic and hypertensive eye damage, macular degeneration.
Intraocular pressureGlaucoma.
Visual acuityVision sharpness.
ENT & Dental
Hearing testHearing loss.
Vitals
Body composition analysis
Body fat, muscle mass and water percentage.
Blood Count
Antinuclear antibody (ANA)
Autoimmune disease screening (e.g. lupus).
Complete blood count
Anemia, infection and blood cell disorders.
White blood cell differential
Breakdown of white cell types; infection, allergy and some blood cancers.
Liver Function
Alkaline phosphatase
Liver, bile duct and bone conditions.
ALT (SGPT)
Liver cell damage; the most common liver screening test.
AST (SGOT)
Liver cell damage.
Gamma-GT
Bile duct and alcohol-related liver stress.
Kidney & Electrolytes
Blood urea nitrogen
Kidney function.
Calcium
Bone, parathyroid and kidney conditions.
Creatinine
Kidney function.
Estimated GFR
Kidney filtering capacity; stages chronic kidney disease.
Electrolytes (Na, K, Cl)
Salt and fluid balance; kidney and hormone problems.
Uric acid
Gout risk and kidney stone risk.
Lipids & Cardiometabolic
HDL cholesterol
Protective cholesterol level.
High-sensitivity CRP
Inflammation linked to heart disease risk.
LDL cholesterol
The main cholesterol driving heart disease risk.
Total cholesterol
Cardiovascular risk.
Triglycerides
Cardiovascular and pancreatitis risk.
Glucose
Fasting glucose
Diabetes and prediabetes.
Hemoglobin A1c
Average blood sugar over the past three months; diabetes.
Thyroid & Endocrine
Free T4
Thyroid hormone level.
TSH
Thyroid function; the primary thyroid screening test.
Tumor Markers
AFP
Liver cancer marker (also used with liver ultrasound in hepatitis B carriers).
CEA
Colorectal and other GI cancer marker.
Free PSA ratio
Refines prostate cancer risk when PSA is borderline.
PSA
Prostate cancer marker.
Infection Serology
Hepatitis B core antibody
Past or hidden hepatitis B exposure.
Urine & Stool
Urinalysis
Kidney disease, urinary infection, diabetes.
Cardiac
Resting ECG
Heart rhythm and signs of prior heart damage.
Ultrasound
Abdominal ultrasound
Liver (fatty liver, tumors), gallbladder stones, pancreas, spleen and kidneys.
Breast ultrasound
Breast lumps; complements mammography, especially in dense breasts.
Pelvic (gynecologic) ultrasound
Uterus and ovary abnormalities (fibroids, cysts).
Thyroid ultrasound
Thyroid nodules.
CT Imaging
Low-dose chest CT
Early lung cancer; the USPSTF recommends it yearly for some adults 50 to 80 with a heavy smoking history.
Women's Health
Mammography
Breast cancer; the standard screen for women 40+.
Men's Health
Uroflowmetry
Prostate enlargement effect on urination.
Bone & Body Composition
Bone density (DXA)
Osteoporosis and fracture risk.
Eye
Retinal (fundus) photography
Diabetic and hypertensive eye damage, macular degeneration.
Intraocular pressure
Glaucoma.
Visual acuity
Vision sharpness.
ENT & Dental
Hearing test
Hearing loss.
Also listed: CA 15-3, CA 19-9, CA-125, Direct bilirubin, EBV VCA IgA antibody, EBV early antigen IgA antibody, Gynecology consultation and liquid-based Pap smear, H. pylori stool antigen test, Hepatitis B surface antigen and antibody, Hepatitis C antibody, Insulin and insulin resistance analysis, Internal medicine checkup report compilation and consultation, Internal medicine examination, Liver elastography (FibroScan), Metabolic syndrome, Prostate Health Index (PHI), Quantitative fecal immunochemical test (FIT), Total bilirubin, Total cholesterol risk ratio.

Before you book

If something is foundAsk the hospital how any findings are explained, on the day or at a follow-up appointment; in Book it for me we ask for you and tell you before you book. Your own doctor decides what to do next; we do not arrange treatment.
Results and imagingAsk the hospital how long results take and how imaging is delivered; in Book it for me we ask for you and tell you before you book.
National Taiwan University Cancer Center
Regional hospital
Taipei · Daan

About 13 minutes' walk (973 m) from Gongguan station

3 packages listed

About this hospital

What the center says

From the center's own pages, in English. Each statement links to its source.

Booking and payment
  • The center says international patients from overseas should show a foreign passport when receiving care, and it does not accept the Taiwan NHI card.

    Source ↗ · checked 2026-09-20

  • The center says its international-patient service is for people holding a foreign passport without Taiwan NHI coverage, and that such patients pay entirely out of pocket rather than through NHI.

    Source ↗ · checked 2026-09-20

  • The center accepts cash, credit card (American Express excepted), or bank transfer.

    Source ↗ · checked 2026-09-20

  • The center says it can issue receipts in Chinese or English (one or the other), and asks patients to specify their choice in advance.

    Source ↗ · checked 2026-09-20

  • For special needs, the center says patients can ask their doctor in advance to issue a diagnosis certificate to help with insurance claims.

    Source ↗ · checked 2026-09-20

Add to this package

Tests this center prices separately that this package does not include.

TestPriceNote
Lipoprotein(a)
US$11
NT$358
The add-on price list is marked as available only with the anti-cancer standard package base package.
Female hormone panel (FSH, LH, E2)as listed: Female hormone panel
US$14
NT$450
For women · The add-on price list is marked as available only with the anti-cancer standard package base package.
Vitamin D (25-OH)as listed: Vitamin D
US$29
NT$920
The add-on price list is marked as available only with the anti-cancer standard package base package.
Arterial stiffness (ABI / PWV)as listed: Arterial stiffness analysis (ABI/PWV)
US$47
NT$1,521
The add-on price list is marked as available only with the anti-cancer standard package base package.
Echocardiogram
US$136
NT$4,368
The add-on price list is marked as available only with the anti-cancer standard package base package.
Carotid ultrasound
US$106
NT$3,400
The add-on price list is marked as available only with the anti-cancer standard package base package.
Coronary artery calcium scoreas listed: Coronary artery calcium score CT
US$187
NT$6,000
The add-on price list is marked as available only with the anti-cancer standard package base package.
Coronary CT angiography
US$779
NT$25,000
The add-on price list is marked as available only with the anti-cancer standard package base package.
Pelvic MRI
US$263
NT$8,450
The add-on price list is marked as available only with the anti-cancer standard package base package.
Whole spine MRIas listed: Cervical, thoracic and lumbar spine MRI (whole spine)
US$415
NT$13,334
The add-on price list is marked as available only with the anti-cancer standard package base package.
Prostate MRI (multiparametric)as listed: Non-invasive prostate imaging (contrast-enhanced prostate MRI)
US$466
NT$14,950
For men · The add-on price list is marked as available only with the anti-cancer standard package base package.
PET-CT (FDG)as listed: Whole-body PET-CT
US$1,137
NT$36,500
The add-on price list is marked as available only with the anti-cancer standard package base package.

Source ↗ · checked 2026-09-20

US price context

Bought one by one at US cash-pay marketplaces, the tests we could price list at about US$2,502–3,444 for a woman (39 of 39 tests) and US$1,858–2,678 for a man (38 of 39 tests) (MDsave, Quest and others; checked 2026-10-11).

How we priced it

A panel counts once however many of its tests the package lists. A test for one sex only is counted only for that sex. Tests we could not price are left out, so this is not what a US checkup would cost. Prices marked "rough" come from a single reseller or are extrapolated from a similar test.

Radiation from this package's imaging

About 1.8 mSv from the tests we could identify, a typical adult dose for these exams: roughly 7 months of natural background radiation (about 3 mSv a year, US average).

Not counted: Liver elastography (FibroScan). If it is an X-ray, CT or PET scan, the total is higher.

  • Bone density (DXA) · about less than 0.01 mSv
  • Low-dose chest CT · about 1.5 mSv
  • Mammography · about 0.28 mSv

Typical doses from published references (RadiologyInfo.org ↗, Mettler et al. 2008 ↗); the actual dose depends on the scanner and protocol. Ask the center for its own figure.

What US screening guidelines say

The US Preventive Services Task Force is an independent US panel whose recommendations cover people without symptoms. Shown for comparison; it is not advice for you.

What US screening guidelines say about 21 of these tests
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for hearing loss in adults 50 years or older. (2021) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in postmenopausal women younger than 65 years who are at increased risk, based on a clinical risk-assessment tool. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for osteoporosis in men. (2025) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends screening for osteoporosis with bone density testing in women 65 years or older. (2025) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of supplemental screening with breast ultrasound in women found to have dense breasts on an otherwise negative screening mammogram. (2024) · USPSTF ↗ Note: Same I statement covers ultrasound and MRI as supplemental tests; see mri_breast. The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a fasting plasma glucose test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Selective (grade C)The USPSTF says the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one for men aged 55 to 69 years. (2018; an update is in progress) · USPSTF ↗ Note: The recommendation states evidence is insufficient that using a prebiopsy risk calculator, with or without free PSA, meaningfully changes the benefits and harms of screening; the USPSTF does not grade free PSA separately, so this file shows the PSA-screening grades. The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years or older. (2018; an update is in progress) · USPSTF ↗ Note: The recommendation states evidence is insufficient that using a prebiopsy risk calculator, with or without free PSA, meaningfully changes the benefits and harms of screening; the USPSTF does not grade free PSA separately, so this file shows the PSA-screening grades. The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for primary open-angle glaucoma in adults. (2022) · USPSTF ↗ Note: Same I-statement covers tonometry (intraocular pressure), optic-nerve/fundus imaging and OCT as candidate glaucoma-screening methods.
Recommended (grade A/B)The USPSTF recommends screening for prediabetes and type 2 diabetes, including with a hemoglobin A1c test, in adults aged 35 to 70 years who have overweight or obesity. (2021) · USPSTF ↗ Note: Same recommendation names fasting plasma glucose, HbA1c and the oral glucose tolerance test as acceptable screening tests. The USPSTF suggests clinicians consider screening at an earlier age in groups with higher diabetes prevalence, including Asian American persons, and at a lower BMI (23 or higher) in Asian American persons.
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of adding high-sensitivity CRP to traditional risk assessment for cardiovascular disease in asymptomatic adults. (2018) · USPSTF ↗ Note: Same recommendation covers ABI, high-sensitivity CRP and coronary artery calcium score together; see the other two test rows. The USPSTF lists an update in progress for this statement, but the key questions in its research plan cover coronary artery calcium scoring only, not hs-CRP.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for primary open-angle glaucoma in adults. (2022) · USPSTF ↗ Note: Same I-statement covers tonometry (intraocular pressure), optic-nerve/fundus imaging and OCT as candidate glaucoma-screening methods.
Recommended (grade A/B)The USPSTF recommends annual screening for lung cancer with low-dose CT in adults aged 50 to 80 years with a 20 pack-year smoking history who currently smoke or quit within the past 15 years. (2021) · USPSTF ↗ Note: Screening should stop once the person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability to have curative lung surgery.
Recommended (grade A/B)The USPSTF recommends biennial screening mammography for women aged 40 to 74 years. (2024) · USPSTF ↗ Note: The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening mammography in women 75 years or older. (2024) · USPSTF ↗ Note: The USPSTF breast cancer screening statement does not apply to people at high risk of breast cancer (for example BRCA1/2 carriers or others with a high-risk genetic marker or syndrome, people who had high-dose chest radiation at a young age, or people with previous breast cancer or a high-risk breast lesion).
Recommended against (grade D)The USPSTF recommends against screening for ovarian cancer in asymptomatic women, including with transvaginal ultrasound. (2018) · USPSTF ↗ Note: Same D-grade recommendation covers pelvic/transvaginal ultrasound and the CA-125 blood test; see ca125. This csv does not map pelvic_ultrasound to any recommendation about non-ovarian pelvic findings (fibroids, cysts), which the USPSTF does not address.
Selective (grade C)The USPSTF says the decision to undergo periodic PSA-based screening for prostate cancer should be an individual one for men aged 55 to 69 years. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against PSA-based screening for prostate cancer in men 70 years or older. (2018; an update is in progress) · USPSTF ↗ Note: The USPSTF lists an update of this topic as in progress; the 2018 statement remains the current final recommendation as of 2026-09-25.
Recommended against (grade D)The USPSTF recommends against screening with resting or exercise ECG to prevent cardiovascular disease events in asymptomatic adults at low risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening with resting or exercise ECG to prevent cardiovascular disease events in adults at intermediate or high risk of CVD events. (2018) · USPSTF ↗
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for atrial fibrillation with ECG in adults 50 years or older. (2022) · USPSTF ↗
Recommended against (grade D)The USPSTF recommends against screening for thyroid cancer in asymptomatic adults. (2017) · USPSTF ↗
Recommended (grade A/B)The USPSTF recommends that clinicians prescribe a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 10% or greater. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Selective (grade C)The USPSTF recommends that clinicians selectively offer a statin for the primary prevention of cardiovascular disease for adults aged 40 to 75 years who have 1 or more cardiovascular risk factors and an estimated 10-year cardiovascular risk of 7.5% to less than 10%. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of starting a statin for the primary prevention of cardiovascular disease in adults 76 years or older. (2022) · USPSTF ↗ Note: This grade is for starting a statin, not for the cholesterol test; the USPSTF does not grade cholesterol testing on its own. The USPSTF says the ACC/AHA Pooled Cohort Equations may be used to estimate 10-year risk; per the 2013 ACC/AHA risk-assessment guideline, those equations use total and HDL cholesterol as inputs. The statement does not apply to adults with LDL cholesterol above 190 mg/dL or known familial hypercholesterolemia.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for thyroid dysfunction in nonpregnant, asymptomatic adults. (2015) · USPSTF ↗ Note: The I statement concerns screening for thyroid dysfunction, for which the USPSTF names serum TSH as the primary screening test; T4 is described as follow-up testing after a persistently abnormal TSH.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for bladder cancer in asymptomatic adults. (2011) · USPSTF ↗ Note: The USPSTF lists urine dipstick or microscopic urinalysis for hematuria (blood in the urine) among the bladder cancer screening tests it considered. This note covers only that use of a urinalysis.
Insufficient evidence (grade I)The USPSTF says the evidence is insufficient to weigh the benefits and harms of screening for impaired visual acuity in older adults. (2022) · USPSTF ↗
General preparation notes for 12 tests in this package

This is general information about how the exam is usually done, not medical advice for you or your family member. Requirements vary by center and by individual health history — always follow the center's own instructions and your own doctor's guidance, especially for any medicine change.

Body composition analysis

Mention when booking: Mention a pacemaker or implanted defibrillator: the test passes a weak electric current through the body and has traditionally not been recommended with these devices.

Total cholesterol

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested, so the test is often done in the morning.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Triglycerides

Fasting for 9 to 12 hours (no food or drink except plain water) is often requested.

Mention when booking: Confirm with the center whether your test needs fasting; if you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting.

Fasting glucose

Usually needs at least 8 hours without food or drink except water beforehand.

Mention when booking: If you take insulin or other diabetes medicine, ask the prescribing doctor how to manage it while fasting, and mention it to the center.

Urinalysis

Usually needs a clean-catch (midstream) sample; some tests instead ask you to collect all urine passed over 24 hours.

Mention when booking: Ask which specific urine test your provider ordered, since collection instructions vary by test.

Abdominal ultrasound

Usually needs about 6 hours without food beforehand; clear fluids other than milk or fizzy drinks are commonly still allowed. Loose, comfortable clothing is easiest.

Mention when booking: Mention if you have type 1 diabetes, so the center can offer an early appointment time.

Pelvic (gynecologic) ultrasound

For a transabdominal scan, drinking water beforehand to fill the bladder is common; for a transvaginal scan, an empty bladder is usual instead.

Mention when booking: Tell the center which type of scan you expect, and mention if you are, or might be, pregnant.

Low-dose chest CT

Usually needs no fasting and no contrast injection; loose clothing with no metal is easiest.

Mention when booking: Tell the center if you are, or might be, pregnant.

Mammography

Usually asks that you skip deodorant, powder or lotion on the underarms and breasts, since these can look like calcium spots on the image. Bring prior mammograms from elsewhere if you have them.

Mention when booking: Mention breast implants, any breast symptoms, prior breast surgery, hormone use, or the possibility of pregnancy.

Afterwards: You may be asked to wait until the radiologist confirms the images are complete; ask when to expect results.

Bone density (DXA)

Usually asks that you skip calcium supplements for 24 hours beforehand. Avoid clothing with metal zippers or buttons, and remove jewelry.

Mention when booking: Mention any recent barium exam or CT/nuclear-medicine contrast, and whether pregnancy is possible.

Retinal (fundus) photography

Often done with a camera that photographs the retina without drops; some centers use dilating drops that widen the pupil, which blurs vision for a few hours afterward.

Mention when booking: Mention any eye pain, halos around lights, or a narrow drainage angle or angle-closure glaucoma history.

Afterwards: If drops were used, vision may be blurry and light-sensitive for a few hours; have someone else drive. Sudden eye pain, headache, blurred vision or halos after dilation need urgent care.

Hearing test

Usually needs no special preparation; expect to listen for tones or words through headphones, and sometimes a small probe checks how the eardrum moves.

Sources
As published by the hospital · checked 2026-09-20

How we collect and check these prices: see who we are and where the data comes from.

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.
Package name translated by us from the hospital's Chinese name.
Standard Cancer Prevention Package
US$869
Book this checkup

If this isn't quite right

Other packages at National Taiwan University Cancer Center

All packages at National Taiwan University Cancer Center →

Similar packages in Taipei

All checkups in Taipei →

US$ at 32.1 TWD, 23 Sep 2026; you pay in NT$.

Browse: Cancer screening · All checkups in Taipei · What a checkup costs in Taiwan